GOODMAN DANIEL WINTNER enters TONIX PHARMACEUTICALS HOLDING CORP. with 7.00 shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 5/8/2019ACC: 0001387131-19-003413
Director
Since May 2019
7.00
Baseline shares
100% direct
7.00
Direct ownership
1 position
30.05K
Derivative underlying
2 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock, $0.001 par value
DirectShares owned7.00
Total
7.00 direct7.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock, $0.001 par value | 7.00 | Direct |
| Total | 7.00 | 7.00 direct |
Derivative Holdings2
Stock Option
DirectUnderlying security
Common Stock
Underlying shares
50.00
Shares owned
N/A
Exercise price
987.00
Expiration
—
Exercise window
—
Stock Option
DirectUnderlying security
Common Stock
Underlying shares
30K
Shares owned
N/A
Exercise price
2.05
Expiration
—
Exercise window
—
Total
Underlying
30.05K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option Direct | Common Stock | 987.00 | — | — | 50.00 | N/A |
| Stock Option Direct | Common Stock | 2.05 | — | — | 30K | N/A |
| Total | 30.05K | 0.00 | ||||